The mutation statuses of HCT 116 colon cancer cells are KRAS mutation (p.G13D) and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutation (p.H1047R) [17]. Here, KRAS is linked to malignant colon neoplasm.